Monthly Archives: August 2016

This first edition of Telemanagement of Inflammatory Bowel Disease appears to be the first text on telemedicine fully dedicated to inflammatory bowel disease (IBD). The editors and chapter authors (from the United States and Denmark) are all experience… Continue reading →

This first edition of Telemanagement of Inflammatory Bowel Disease appears to be the first text on telemedicine fully dedicated to inflammatory bowel disease (IBD). The editors and chapter authors (from the United States and Denmark) are all experience… Continue reading →

This first edition of Telemanagement of Inflammatory Bowel Disease appears to be the first text on telemedicine fully dedicated to inflammatory bowel disease (IBD). The editors and chapter authors (from the United States and Denmark) are all experience… Continue reading →

We thank Drs Sookoian and Pirola for their thoughtful comments and interest in our recent work. We appreciate the opportunity to broadly discuss the questions raised. Continue reading →

We thank Drs Sookoian and Pirola for their thoughtful comments and interest in our recent work. We appreciate the opportunity to broadly discuss the questions raised. Continue reading →

We thank Drs Sookoian and Pirola for their thoughtful comments and interest in our recent work. We appreciate the opportunity to broadly discuss the questions raised. Continue reading →

The net effect of Helicobacter pylori eradication in asymptomatic individuals can be unfavorable. The systematic review1 associates eradication of H pylori infection with a reduced incidence of gastric cancer. The benefits of eradication vary with baseline gastric cancer incidence (which ranged from 34.3 to 10,256.4 per 100,000 persons-years), but the authors state that they apply to all levels of baseline risk. They claim thatresults support mass Hp screening and eradication as a viable preventive strategy, that should be implemented in high-risk populations/areas, especially in those with an incidence rate >150/100,000 person-years [below which the protection loses statistical significance]. Continue reading →

The net effect of Helicobacter pylori eradication in asymptomatic individuals can be unfavorable. The systematic review1 associates eradication of H pylori infection with a reduced incidence of gastric cancer. The benefits of eradication vary with baseline gastric cancer incidence (which ranged from 34.3 to 10,256.4 per 100,000 persons-years), but the authors state that they apply to all levels of baseline risk. They claim thatresults support mass Hp screening and eradication as a viable preventive strategy, that should be implemented in high-risk populations/areas, especially in those with an incidence rate >150/100,000 person-years [below which the protection loses statistical significance]. Continue reading →

The net effect of Helicobacter pylori eradication in asymptomatic individuals can be unfavorable. The systematic review1 associates eradication of H pylori infection with a reduced incidence of gastric cancer. The benefits of eradication vary with baseline gastric cancer incidence (which ranged from 34.3 to 10,256.4 per 100,000 persons-years), but the authors state that they apply to all levels of baseline risk. They claim thatresults support mass Hp screening and eradication as a viable preventive strategy, that should be implemented in high-risk populations/areas, especially in those with an incidence rate >150/100,000 person-years [below which the protection loses statistical significance]. Continue reading →

The liver-derived peptide hepcidin is the master regulator of systemic iron homeostasis in mammals. Expression depends on multiple signals: extracellular and intracellular iron, inflammation, and erythropoiesis. Bone morphogenetic protein 6 (BMP6) is a… Continue reading →